147 related articles for article (PubMed ID: 37082061)
41. A clinic-pathological research explored the significance of ascorbic acid and iron levels in serum and saliva in premalignant disorder patients at Kanpur, Uttar Pradesh.
Sachdev R; Garg K; Mehrotra V; Shwetam S; Singh P; Srivastava A
Natl J Maxillofac Surg; 2024; 15(1):131-135. PubMed ID: 38690244
[TBL] [Abstract][Full Text] [Related]
42. Comparison of salivary flow and candidal carriage in patients with oral submucous fibrosis.
Gupta B; Chandra S; Raj V; Gupta V
J Oral Maxillofac Pathol; 2015; 19(2):158-63. PubMed ID: 26604490
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of p16 hypermethylation in oral submucous fibrosis: A quantitative and comparative analysis in buccal cells and saliva using real-time methylation-specific polymerase chain reaction.
Kaliyaperumal S; Sankarapandian S
South Asian J Cancer; 2016; 5(2):73-9. PubMed ID: 27275454
[TBL] [Abstract][Full Text] [Related]
44. Correlation of salivary and serum IgG, IgA levels with total protein in oral submucous fibrosis.
Patidar KA; Parwani RN; Wanjari SP
J Oral Sci; 2011 Mar; 53(1):97-102. PubMed ID: 21467820
[TBL] [Abstract][Full Text] [Related]
45. Oral submucous fibrosis: A quantitative assessment of serum malondialdehyde, superoxide dismutase and correlation with clinical staging.
Bale R; Kattappagari KK; Vidya D; Vuddandi S; Gummalla C; Baddam VRR
J Oral Maxillofac Pathol; 2017; 21(1):41-45. PubMed ID: 28479685
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of myofibroblasts in oral submucous fibrosis and oral squamous cell carcinoma: The pathogenesis and correlation.
Gandhi P; Prasad UC
Dent Res J (Isfahan); 2017; 14(5):314-320. PubMed ID: 29109745
[TBL] [Abstract][Full Text] [Related]
47. Assessment of salivary endothelin-1 in patients with leukoplakia, submucous fibrosis, oral cancer and healthy individuals - a comparative study.
Ankita K; Shwetha V; Vanitha S; Reddy Sujatha S; Nagaraju R; Tupakula Pavan K
J Stomatol Oral Maxillofac Surg; 2019 Sep; 120(4):326-331. PubMed ID: 30858129
[TBL] [Abstract][Full Text] [Related]
48. Assessment of C-Reactive Protein Level in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma Patient.
Sharma G; Kumar R; Salam SA; Bhasin P; Tewari NK; Yadav S
J Pharm Bioallied Sci; 2021 Jun; 13(Suppl 1):S748-S750. PubMed ID: 34447194
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of serum immunoglobulin (IgG, IgM, IgA) in potentially malignant disorders of oral cavity - A case control study.
Tarsariya VM; Mehta DN; Raval N; Patadiya HH; Vachhrajani K; Ashem A
J Oral Biol Craniofac Res; 2020; 10(4):665-669. PubMed ID: 33005564
[TBL] [Abstract][Full Text] [Related]
50. The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis.
Chaudhary M; Bajaj S; Bohra S; Swastika N; Hande A
J Oral Maxillofac Pathol; 2015; 19(2):122-7. PubMed ID: 26604484
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of myofibroblasts by expression of alpha smooth muscle actin: a marker in fibrosis, dysplasia and carcinoma.
Rao K B; Malathi N; Narashiman S; Rajan ST
J Clin Diagn Res; 2014 Apr; 8(4):ZC14-7. PubMed ID: 24959509
[TBL] [Abstract][Full Text] [Related]
52. Expression of Ki67 Biomarker in Oral Submucous Fibrosis with Clinico-Pathological Correlations: A Prospective Study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
Asian Pac J Cancer Prev; 2022 Jan; 23(1):253-259. PubMed ID: 35092395
[TBL] [Abstract][Full Text] [Related]
53. Immunoexpression of alpha smooth muscle actin correlates with serum transforming growth factor-β1 levels in oral submucous fibrosis.
Singh I; Juneja S; Tandon A; Jain A; Shetty DC; Sethi A
J Investig Clin Dent; 2019 Nov; 10(4):e12473. PubMed ID: 31631564
[TBL] [Abstract][Full Text] [Related]
54. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma.
Zhang SY; Lin BD; Li BR
FEBS Open Bio; 2015; 5():240-4. PubMed ID: 25870783
[TBL] [Abstract][Full Text] [Related]
56. Estimation and correlative study of salivary nitrate and nitrite in tobacco related oral squamous carcinoma and submucous fibrosis.
Shende V; Biviji A; Akarte N
J Oral Maxillofac Pathol; 2013 Sep; 17(3):381-5. PubMed ID: 24574656
[TBL] [Abstract][Full Text] [Related]
57. Serum vitamin c and iron levels in oral submucous fibrosis.
Guruprasad R; Nair PP; Singh M; Singh M; Singh M; Jain A
Indian J Dent; 2014 Apr; 5(2):81-5. PubMed ID: 25565730
[TBL] [Abstract][Full Text] [Related]
58. Serum uric acid levels in patients with oral cancer, leukoplakia and submucous fibrosis: a cross-sectional study.
Yadav KD; Patil BA; Raheel SA; Abuderman A; Patil S; Gaballah K; Kujan O
Transl Cancer Res; 2020 Apr; 9(4):3084-3091. PubMed ID: 35117671
[TBL] [Abstract][Full Text] [Related]
59. Lactate Dehydrogenase as a Biomarker in Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis.
Mahapatra M; Panda A; Kumar H; Barman D; Talukdar R; Dakshinakabat P
Cureus; 2023 Dec; 15(12):e51008. PubMed ID: 38264399
[TBL] [Abstract][Full Text] [Related]
60. Role of oxidative stress in the pathogenesis of oral submucous fibrosis: A preliminary prospective study.
Shakunthala GK; Annigeri RG; Arunkumar S
Contemp Clin Dent; 2015 Sep; 6(Suppl 1):S172-4. PubMed ID: 26604570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]